The 36th International Symposium on Microscale Separations and Bioanalysis (MSB2020) will take place at the Conference Center Le Grand Large in the city of Saint‑Malo, France, from 5–8 April 2020.
Photo Credit: antoine2k/stock.adobe.com
The 36th International Symposium on Microscale Separations and Bioanalysis (MSB2020) will take place at the Conference Center Le Grand Large in the city of SaintâMalo, France, from 5–8 April 2020.
More than 250 international scientists, researchers, other academics, and industrial members will gather for the four-day symposium to discuss the latest trends in all major microscale separation techniques, including CE, nano-LC, microfluidics, MS, CE-MS, and lab-on-chip devices, independent of whether they are pressure- or electrically-driven.
The programme comprises 13 topic sessions, three plenary lectures, 18 keynotes, and numerous oral presentations in two parallel tracks, giving the participants the opportunity to attend most of the talks. The programme covers all aspects of microscale separations and applications related to systems biology, pharmaceutical sciences, biotechnology, clinical diagnostics, food and health, nanoparticles, industrial chemicals, and advanced detection and instrumentation.
Up to three pre-congress courses are offered, as well as one workshop on the construction of an open-source CE system. This workshop will continue throughout the duration of MSB and will be a common thread during the congress.
For more information visit: www.msb2020.com or e-mail: info@msb2020.com
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.